10. Fentora - Top 10 Warnings and Recalls

Drug: Fentora

2006 sales: $370 million

Manufacturer: Cephalon

Safety concern: Warning; improper dosing leading to death

Related Articles:
> New warning for off-label Fentora. Report
> Red flags raised on Fentora misuse. Report
> FDA approves Fentora for cancer pain. Report
> Cephalon shares jump on Fentora decision. Report
> Cephalon takes heat for off-label narcotic promotion. Report

10. Fentora - Top 10 Warnings and Recalls

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.